168 related articles for article (PubMed ID: 30585398)
1. Granulocytic myeloid-derived suppressor cell population increases with the severity of alcoholic liver disease.
Gao M; Huang A; Sun Z; Sun Y; Chang B; Zhang JY; Zou ZS
J Cell Mol Med; 2019 Mar; 23(3):2032-2041. PubMed ID: 30585398
[TBL] [Abstract][Full Text] [Related]
2. [Effect of gMDSCs on natural killer cell functionality in chronic hepatitis C patients treated with direct-acting antiviral agents].
Shi JJ; Zhou WJ; Lu C; Jia XY; Chang WX; Zhang JY; Li YY; Mu XL
Zhonghua Yi Xue Za Zhi; 2021 Jul; 101(27):2133-2139. PubMed ID: 34275248
[No Abstract] [Full Text] [Related]
3. Metabolic regulation of hepatitis B immunopathology by myeloid-derived suppressor cells.
Pallett LJ; Gill US; Quaglia A; Sinclair LV; Jover-Cobos M; Schurich A; Singh KP; Thomas N; Das A; Chen A; Fusai G; Bertoletti A; Cantrell DA; Kennedy PT; Davies NA; Haniffa M; Maini MK
Nat Med; 2015 Jun; 21(6):591-600. PubMed ID: 25962123
[TBL] [Abstract][Full Text] [Related]
4. Expansion of granulocytic myeloid-derived suppressor cells in patients with severe fever with thrombocytopenia syndrome.
Du J; Li XK; Peng XF; Xu W; Zhang XA; Li H; Yang T; Yuan C; Chen WW; Li C; Lu QB; Liu W
J Med Virol; 2022 Sep; 94(9):4329-4337. PubMed ID: 35562326
[TBL] [Abstract][Full Text] [Related]
5. Granulocytic and Monocytic Myeloid-Derived Suppressor Cells are Functionally and Prognostically Different in Patients with Chronic Myeloid Leukemia.
Ahn A; Park CJ; Kim MS; Cho YU; Jang S; Bae MH; Lee JH; Lee JH; Koh KN; Im HJ
Ann Lab Med; 2021 Sep; 41(5):479-484. PubMed ID: 33824236
[TBL] [Abstract][Full Text] [Related]
6. Current Status of Alcoholic Liver Disease in Japan and Therapeutic Strategy.
Horie Y; Ebinuma H; Kikuchi M; Lamao Takanori
Nihon Arukoru Yakubutsu Igakkai Zasshi; 2016 Aug; 51(2):71-90. PubMed ID: 30462383
[TBL] [Abstract][Full Text] [Related]
7. Activated hepatic stellate cells promote liver cancer by induction of myeloid-derived suppressor cells through cyclooxygenase-2.
Xu Y; Zhao W; Xu J; Li J; Hong Z; Yin Z; Wang X
Oncotarget; 2016 Feb; 7(8):8866-78. PubMed ID: 26758420
[TBL] [Abstract][Full Text] [Related]
8. Marked 25-hydroxyvitamin D deficiency is associated with poor prognosis in patients with alcoholic liver disease.
Trépo E; Ouziel R; Pradat P; Momozawa Y; Quertinmont E; Gervy C; Gustot T; Degré D; Vercruysse V; Deltenre P; Verset L; Gulbis B; Franchimont D; Devière J; Lemmers A; Moreno C
J Hepatol; 2013 Aug; 59(2):344-50. PubMed ID: 23557869
[TBL] [Abstract][Full Text] [Related]
9. Alcoholic liver disease: A registry view on comorbidities and disease prediction.
Grissa D; Nytoft Rasmussen D; Krag A; Brunak S; Juhl Jensen L
PLoS Comput Biol; 2020 Sep; 16(9):e1008244. PubMed ID: 32960884
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA expression profiles of granulocytic myeloid‑derived suppressor cells from mice bearing Lewis lung carcinoma.
Jiang J; Gao Q; Wang T; Lin H; Zhan Q; Chu Z; Huang R; Zhou X; Liang X; Guo W
Mol Med Rep; 2016 Nov; 14(5):4567-4574. PubMed ID: 27748875
[TBL] [Abstract][Full Text] [Related]
11. Histological parameters and alcohol abstinence determine long-term prognosis in patients with alcoholic liver disease.
Lackner C; Spindelboeck W; Haybaeck J; Douschan P; Rainer F; Terracciano L; Haas J; Berghold A; Bataller R; Stauber RE
J Hepatol; 2017 Mar; 66(3):610-618. PubMed ID: 27894795
[TBL] [Abstract][Full Text] [Related]
12. Altered Frequency, Activation, and Clinical Relevance of Circulating Innate and Innate-Like Lymphocytes in Patients With Alcoholic Liver Cirrhosis.
Park KJ; Jin HM; Cho YN; Yoon JH; Kee SJ; Kim HS; Park YW
Immune Netw; 2023 Jun; 23(3):e22. PubMed ID: 37416928
[TBL] [Abstract][Full Text] [Related]
13. Alcoholic liver disease confers a worse prognosis than HCV infection and non-alcoholic fatty liver disease among patients with cirrhosis: An observational study.
Marot A; Henrion J; Knebel JF; Moreno C; Deltenre P
PLoS One; 2017; 12(10):e0186715. PubMed ID: 29077714
[TBL] [Abstract][Full Text] [Related]
14. A core of differentially methylated CpG loci in gMDSCs isolated from neonatal and adult sources.
Berglund-Brown I; Nissen E; Koestler DC; Butler RA; Eliot MN; Padbury JF; Salas LA; Molinaro AM; Christensen BC; Wiencke JK; Kelsey KT
Clin Epigenetics; 2022 Feb; 14(1):27. PubMed ID: 35189960
[TBL] [Abstract][Full Text] [Related]
15. Decreased natural killer cytotoxic activity in chronic alcoholism is associated with alcohol liver disease but not active ethanol consumption.
Laso FJ; Madruga JI; Girón JA; López A; Ciudad J; San Miguel JF; Alvarez-Mon M; Orfao A
Hepatology; 1997 May; 25(5):1096-100. PubMed ID: 9141423
[TBL] [Abstract][Full Text] [Related]
16. Quantitative morphology of mitochondria in hepatocellular carcinoma and chronic liver disease.
Wu PC; Lai CL; Liddel RH
Arch Pathol Lab Med; 1984 Nov; 108(11):914-6. PubMed ID: 6091592
[TBL] [Abstract][Full Text] [Related]
17. Granulocytic myeloid-derived suppressor cells inversely correlate with plasma arginine and overall survival in critically ill patients.
Gey A; Tadie JM; Caumont-Prim A; Hauw-Berlemont C; Cynober L; Fagon JY; Terme M; Diehl JL; Delclaux C; Tartour E
Clin Exp Immunol; 2015 May; 180(2):280-8. PubMed ID: 25476957
[TBL] [Abstract][Full Text] [Related]
18. Characterization of a whole blood assay for quantifying myeloid-derived suppressor cells.
Apodaca MC; Wright AE; Riggins AM; Harris WP; Yeung RS; Yu L; Morishima C
J Immunother Cancer; 2019 Aug; 7(1):230. PubMed ID: 31462270
[TBL] [Abstract][Full Text] [Related]
19. Disease spectrum of alcoholic liver disease in Beijing 302 Hospital from 2002 to 2013: A large tertiary referral hospital experience from 7422 patients.
Huang A; Chang B; Sun Y; Lin H; Li B; Teng G; Zou ZS
Medicine (Baltimore); 2017 Feb; 96(7):e6163. PubMed ID: 28207552
[TBL] [Abstract][Full Text] [Related]
20. The clinicopathological spectrum of alcoholic liver disease--an autopsy survey of 441 cases.
Liew CT
Changgeng Yi Xue Za Zhi; 1990 Jun; 13(2):72-85. PubMed ID: 2171737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
